Tobin (Toby) Schilke, MBA

Tobin (Toby) Schilke is the Chief Financial Officer (CFO) at Revance Therapeutics, Inc., a position he has held since November 2018. He brings extensive experience in the biopharmaceutical finance sector, where he is recognized as a proven leader and trusted advisor.

Education

Schilke has a strong educational background, including:

• Bachelor of Science in Chemical Engineering from Lafayette College (1992 - 1996)
• Master of Science in Chemical Engineering from the University of California, Berkeley (1996 - 1998)
• MBA in Finance from Cornell University - S.C. Johnson Graduate School of Management (2001 - 2003) .12

Professional Experience

Before joining Revance, Schilke accumulated significant experience in capital structure planning and financial management within the biopharmaceutical industry. His leadership at Revance is part of a broader commitment to innovation and excellence in healthcare, as the company aims to set new standards in the industry. His role involves overseeing financial strategies that support the company's growth and product commercialization efforts .12

Schilke's contributions to Revance and his participation in industry conferences highlight his active involvement in the biopharmaceutical field, further establishing his reputation as a key figure in healthcare finance .345